Abstract:OBJECTIVE:To investigate the metabolism of lipid, calcium and phosphorus in women with endometriosis. METHODS:Clinical data of 223 patients with endometriosis and 200 patients without endometriosis were retrospectively analyzed. Electrochemiluminoimmunoassay was used to detect the levels of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), estradiol (E2) and progesterone (P), and photoelectric colorimetry was used to determine the concentrations of serum triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), calcium and phosphorus in the patients with and without endometriosis. RESULTS:The levels of serum P were 2.0 nmol/L and 1.8 nmol/L in endometriosis patients with age < or = 35 years old (case group A) and > 35 years old (case group B), and 1.6 nmol/L and 1.2 nmol/L in patients without endometriosis at age < or = 35 years old (control group A) and > 35 years old (control group B), respectively. A significant difference was found between case group A and control group A, and between case group B and control group B. The levels of serum LH was significantly higher in case group B (7.2 U/L) than that in control group B (6.1 U/L), however, there was no significant difference between case group A (7.0 U/L) and control group A (6.5 U/L). Also no significant difference in serum FSH, T and E2 levels was found between case group A (respectively, 6.2 U/L, 1.1 nmol/L and 269 pmol/L) and control group A (respectively, 6.3 U/L, 1.1 nmol/L and 264 pmol/L), also between case group B (respectively, 6.6 U/L, 1.0 nmol/L and 345 pmol/L) and control group B (6.6 IU/L, 0.9 nmol/L and 279 pmol/L). The concentrations of serum TG in case group A and B (0.71 mmol/L and 0.72 mmol/L) were significantly lower than in control group A and B (0.92 mmol/L and 1.08 mmol/L), respectively. The concentrations of serum LDL in case group A and B [(2.2 +/- 0.5) mmol/L and (2.4 +/- 0.6) mmol/L]were also significantly lower than in control group A and B [(2.4 +/- 0.7) mmol/L and (2.62 +/- 0.63) mmol/L], respectively. However, the concentrations of serum HDL in case group A and B [(1.62 +/- 0.31) mmol/L and (1.53 +/- 0.32) mmol/L] were significantly higher than in control group A and B [(1.48 +/- 0.21) mmol/L and (1.37 +/- 0.22) mmol/L] , respectively. In addition, the concentrations of serum TC were not significantly different between case group A and control group A [(4.2 +/- 0.7) mmol/L and (4.29 +/- 0.71) mmol/L], and between case group B and control group B [(4.4 +/- 0.8) mmol/L and (4.5 +/- 0.7) mmol/L]. The levels of serum phosphorus in case group A and B [(1.01 +/- 0.22) mmol/L and (0.89 +/- 0.18 mmol/L] were significantly lower than in control group A and B [1.23 +/- 0.24 mmol/L and (1.10 +/- 0.13) mmol/L], respectively. But the levels of serum calcium had no significant difference between case group A and control group A [(2.33 +/- 0.23) mmol/L and (2.41 +/- 0.12) mmol/L], and between case group B and control group B [(2.40 +/- 0.28) mmol/L and (2.42 +/- 0.20) mmol/L]. CONCLUSION:The abnormal metabolism of lipid and phosphorus, and the higher levels of serum P may playing a role in the pathogenesis of endometriosis.

Association of Estrogen Receptor Gene Restriction Fragment Length Polymorphisms and Endometriosis

Research on Relationship Between Gene Polymorphisms of Interleukin-1 Family and Endometriosis

Relationship Between IL-10 Promoter Gene Polymorphisms and the Susceptibility to Endometriosis

Interleukin-10 Gene Promoter Polymorphisms and Their Protein Production in Peritoneal Fluid in Patients with Endometriosis

Research on the Relationship Between Interleukin-1 Receptor Antagonist and Endometriosis

Association of Gene Polymorphisms of Estrogen Receptor Alpha with Endometriosis

Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population.

[Associations of Metabolism of Lipid, Calcium and Phosphate in Endometriosis].

Research on the Correlations Between Interleukin-10 Gene Promoter Polymorphisms and Their Protein Production in Serum and Peritoneal Fluid in Patients with Endometriosis

Estrogen Receptor Α Gene PvuII Polymorphism and Coronary Artery Disease: a Meta-Analysis of 21 Studies.

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Genetic Polymorphisms in the Estrogen Receptor Α Gene and Risk of Breast Cancer

Reduced Alternative Splicing of Estrogen Receptor Alpha in the Endometrium of Women with Endometriosis.

Artificial Intelligence Based Study Association between p53 Gene Polymorphism and Endometriosis: A Systematic Review and Meta-analysis

Association between estrogen receptor gene polymorphisms and rheumatoid arthritis in Chinese women

Genetic Variation In The Estrogen Receptor-Alpha Gene (Esr1), Estrogen Exposure, And Risk Of Endometrial Cancer.

Association of Estrogen Receptor-α Gene Polymorphisms with Severity of Coronary Artery Disease

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

Estrogen receptor gene polymorphism and its association with clinicopathological manifestation of lupus nephritis

Association of endometriosis risk and genetic polymorphisms involving sex steroid biosynthesis and their receptors: a meta-analysis.

Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined.